Steroid therapy in children with fulminant hepatitis A

被引:8
作者
Zakaria, H. M. [1 ,2 ]
Salem, T. A. [1 ]
El-Araby, H. A. [1 ]
Salama, R. M. [1 ]
Elbadry, D. Y. [1 ]
Sira, A. M. [1 ]
Ali, M. A. [1 ]
Salem, M. E. [1 ]
Abd-Alaaty, B. M. [1 ]
Goda, S. S. [1 ]
Eltaras, S. M. [1 ]
Khalil, F. O. [3 ]
Abou-Zeinah, S. S. [1 ]
Sira, M. M. [1 ]
机构
[1] Menofiya Univ, Pediat Hepatol Gastroenterol & Nutr Dept, Natl Liver Inst, Menofiya, Egypt
[2] Minist Hlth, Dept Pediat, Quesna Cent Hosp, Menofiya, Egypt
[3] Menofiya Univ, Dept Microbiol & Immunol, Natl Liver Inst, Menofiya, Egypt
关键词
encephalopathy; liver failure; methylprednisolone; prednisolone; ACUTE LIVER-FAILURE; ACUTE VIRAL-HEPATITIS; RANDOMIZED-TRIAL; AUTOIMMUNE HEPATITIS; CORTICOSTEROIDS; CORTISONE; ACTH; AUTOANTIBODIES; INFECTION;
D O I
10.1111/jvh.12873
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Fulminant hepatic failure is a life-threatening disease. Hepatitis A virus (HAV) can cause fulminant hepatic failure and death in about 0.2% of cases. Extensive destruction of infected hepatocytes by immune-mediated lysis is thought to be the cause. We aimed to evaluate the use of steroid therapy in children with fulminant HAV. This study included 33 children with fulminant HAV in two groups. Steroid group: comprised of 18 children who received prednisolone (1mg/kg/d) or its equivalent dose of methylprednisolone, and the nonsteroid group: comprised another 15 children who did not receive steroid therapy. Age and sex were matched for both groups (P>.05), and they were comparable regarding baseline clinical and laboratory characteristics. Of the steroid group, 15 patients survived and 3 died, while in the nonsteroid group, 4 patients survived and 11 died (P=.001). Of the living patients, 15 of 19 (78.9%) received steroids while only 3 of 14 (21.4%) of the dead patients received steroids (P=.001). Stepwise regression analysis showed that steroid therapy was the only independent variable associated with recovery (P=.001). Steroid therapy in children with fulminant HAV associated significantly with improved outcome and survival. Future studies on a larger population size are strongly recommended.
引用
收藏
页码:853 / 859
页数:7
相关论文
共 35 条
  • [1] Serological markers of autoimmunity in children with hepatitis A: relation to acute and fulminant presentation
    Abdel-Ghaffar, Tawhida Y.
    Sira, Mostafa M.
    Sira, Ahmad M.
    Salem, Tahany A.
    El-Sharawy, Ahmed A.
    El Naghi, Suzan
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 27 (10) : 1161 - 1169
  • [2] Alam Shahinul, 2009, Saudi J Gastroenterol, V15, P229, DOI 10.4103/1319-3767.56094
  • [3] CORTICOSTEROIDS IN TREATMENT OF VIRAL HEPATITIS IN CHILDREN - A CLINICOPATHOLOGICAL COMPARATIVE STUDY
    ATHANASSIADES, T
    NICOLOPOULOS, D
    VLACHOS, J
    VLACHOU, P
    TSENGHI, C
    NICOLAIDES, X
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1967, 114 (03): : 253 - +
  • [4] The significance of autoantibodies and immunoglobulins in acute liver failure: A cohort study
    Berna, William
    Ma, Yun
    Smith, Heather M.
    Portmann, Bernard
    Wendon, Julia
    Vergani, Diego
    [J]. JOURNAL OF HEPATOLOGY, 2007, 47 (05) : 664 - 670
  • [5] Acute liver failure
    Bernal, William
    Auzinger, Georg
    Dhawan, Anil
    Wendon, Julia
    [J]. LANCET, 2010, 376 (9736) : 190 - 201
  • [6] A FORTUITOUSLY CONTROLLED STUDY OF STEROID THERAPY IN ACUTE VIRAL HEPATITIS .I. ACUTE DISEASE
    BLUM, AL
    STUTZ, R
    HAEMMERLI, UP
    SCHMID, P
    GRADY, GF
    [J]. AMERICAN JOURNAL OF MEDICINE, 1969, 47 (01) : 82 - +
  • [7] THE USE OF ACTH IN ACUTE VIRAL HEPATITIS
    COLBERT, JW
    HOLLAND, JF
    HEISSLER, I
    KNOWLTON, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1951, 245 (05) : 172 - 177
  • [8] Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: Therapeutic brinksmanship and the point beyond salvation
    Czaja, Albert J.
    [J]. LIVER TRANSPLANTATION, 2007, 13 (07) : 953 - 955
  • [9] DERITIS F, 1964, LANCET, V1, P533
  • [10] DUCCI H, 1952, GASTROENTEROLOGY, V21, P357